AstraZeneca
AstraZeneca is a powerhouse in the pharmaceutical and biotechnology world. Founded in 1999 through the merger of two established companies, AstraZeneca boasts a rich history dating back to 1913.
With headquarters in Cambridge, England, this British-Swedish multinational company develops and delivers a wide range of treatments across various disease areas. From oncology and cardiovascular to infection and inflammation, AstraZeneca's portfolio addresses some of the world's most pressing health concerns. They've also played a crucial role in developing the Oxford-AstraZeneca COVID-19 vaccine, highlighting their commitment to global health advancements.
Outbound investment captured
AstraZeneca Breaks Ground for New Small Molecule Drug Factory in Wuxi, China
AstraZeneca, a global leader in biopharmaceutical research, recently signed a cooperation agreement with the Wuxi National High-Tech Industrial Development Zone Management Committee to invest $475 million in building a new small molecule drug factory in Wuxi. The groundbreaking ceremony for the new factory was also held today. This is another
SS_editor